HUP9903404A2 - Oxidált oligoszacharidok - Google Patents

Oxidált oligoszacharidok

Info

Publication number
HUP9903404A2
HUP9903404A2 HU9903404A HUP9903404A HUP9903404A2 HU P9903404 A2 HUP9903404 A2 HU P9903404A2 HU 9903404 A HU9903404 A HU 9903404A HU P9903404 A HUP9903404 A HU P9903404A HU P9903404 A2 HUP9903404 A2 HU P9903404A2
Authority
HU
Hungary
Prior art keywords
oxidized
polysaccharides
oxidized oligosaccharides
oligosaccharides
orc
Prior art date
Application number
HU9903404A
Other languages
English (en)
Inventor
Peter John Doyle
Elaine Lorimer
Lowell Saferstein
Paul William Watt
Original Assignee
Johnson & Johnson Medical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Limited filed Critical Johnson & Johnson Medical Limited
Publication of HUP9903404A2 publication Critical patent/HUP9903404A2/hu
Publication of HUP9903404A3 publication Critical patent/HUP9903404A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G3/00—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

A találmány 1 000-50 000 közötti mőlekűlatömegű őligőszacharidőkravőnatkőzik, melyek előállítása az őxidált pőliszacharidők, pl.őxidált, regenerált cellűlóz (ORC) részleges hidrőlízisével történik.Az őligőszacharidőkat sebkötöző szerként és peptidek vagy prőteinekmegkötésére lehet használni. ŕ
HU9903404A 1996-06-28 1997-06-27 Oxidized oligosaccharides HUP9903404A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9613683A GB2314840B (en) 1996-06-28 1996-06-28 Oxidized oligosaccharides and pharmaceutical compositions
PCT/GB1997/001726 WO1998000446A1 (en) 1996-06-28 1997-06-27 Oxidized oligosaccharides

Publications (2)

Publication Number Publication Date
HUP9903404A2 true HUP9903404A2 (hu) 2000-03-28
HUP9903404A3 HUP9903404A3 (en) 2001-03-28

Family

ID=10796095

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903404A HUP9903404A3 (en) 1996-06-28 1997-06-27 Oxidized oligosaccharides

Country Status (16)

Country Link
EP (1) EP0907664B1 (hu)
JP (2) JP4302187B2 (hu)
KR (1) KR20000022286A (hu)
AT (1) ATE195742T1 (hu)
AU (1) AU725296B2 (hu)
BR (1) BR9710003A (hu)
CA (1) CA2258849C (hu)
CZ (1) CZ294839B6 (hu)
DE (1) DE69702911T2 (hu)
ES (1) ES2148991T3 (hu)
GB (1) GB2314840B (hu)
GR (1) GR3034853T3 (hu)
HU (1) HUP9903404A3 (hu)
PL (1) PL189194B1 (hu)
PT (1) PT907664E (hu)
WO (1) WO1998000446A1 (hu)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
GB9900150D0 (en) 1999-01-05 1999-02-24 Unilever Plc Treatment for fabrics
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
AU784607B2 (en) * 2000-05-12 2006-05-11 Systagenix Wound Management Ip Co. B.V. Free radical scavenging compositions
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
AU782756B2 (en) * 2000-05-12 2005-08-25 Systagenix Wound Management Ip Co. B.V. Solid composition exhibiting selective binding to dissolved iron
WO2002087643A1 (fr) * 2001-04-30 2002-11-07 Beijing Textile Research Institute Matieres styptiques de derives ether de cellulose hydrosolubles
US20030118651A1 (en) * 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US20030124087A1 (en) * 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
WO2004024197A1 (en) * 2002-09-11 2004-03-25 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8685943B2 (en) 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
DE10319808A1 (de) * 2003-04-28 2004-11-18 Friedrich-Schiller-Universität Jena Verwendung von Polysaccharid-Derivaten als Mittel zur Stimulierung der Zellproliferation
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
WO2005054297A2 (en) 2003-11-28 2005-06-16 Eastman Chemical Company Cellulose interpolymers and method of oxidation
MX2007003206A (es) * 2004-09-17 2007-10-10 David M Dixon Vendaje para el cuidado de heridas y metodo para utilizarlo.
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
EP2837393A1 (en) 2004-10-20 2015-02-18 Ethicon, Inc. Absorbable hemostat
EP2345430B1 (en) 2004-10-20 2015-11-25 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
WO2007026341A1 (en) * 2005-09-02 2007-03-08 Alltracel Development Services Limited A method for preparing polyanhydroglucuronic acid and/or salts thereof
JP4975996B2 (ja) * 2005-09-30 2012-07-11 東邦化学工業株式会社 カチオン変性ペクチン及び該物質を含む化粧料組成物
GB2444232A (en) 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20090074837A1 (en) * 2007-09-19 2009-03-19 Ut-Battelle, Llc Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite
US9376648B2 (en) 2008-04-07 2016-06-28 The Procter & Gamble Company Foam manipulation compositions containing fine particles
JP2010284216A (ja) * 2009-06-09 2010-12-24 Hogi Medical:Kk カルボキシメチルセルロース構造体及びその製造方法
JP5818055B2 (ja) * 2010-03-17 2015-11-18 静岡県公立大学法人 トリアセチルセルロースブロック共重合体、その中間体、充填剤、および、界面活性剤
US9139662B2 (en) * 2011-03-30 2015-09-22 Nippon Paper Industries Co., Ltd. Method for producing cellulose nanofibers
DE102011007528A1 (de) * 2011-04-15 2012-10-18 Aesculap Aktiengesellschaft Thixotrope Zusammensetzung, insbesondere zur postchirurgischen Adhäsionsprophylaxe
EP2720667A2 (en) * 2011-06-16 2014-04-23 Unilever PLC Aqueous gels
CN104945448B (zh) 2015-05-22 2018-06-19 上海绿谷制药有限公司 一种氧化型β-1,4-寡聚葡萄糖醛酸及其制备方法和用途
CN107849154A (zh) * 2016-06-02 2018-03-27 郡是株式会社 医用纤维结构和医用层压材料
KR102294257B1 (ko) * 2019-04-30 2021-08-26 한양대학교 에리카산학협력단 바이오셀룰로오스-펩티드 복합체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE360128C (de) * 1921-01-03 1922-09-29 Albert Reychler Dr Verfahren zur Herstellung von Staerkeloesungen
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US3598622A (en) * 1969-02-19 1971-08-10 Cpc International Inc Alkali treated starch compositions
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
CA2033046C (en) * 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) * 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
JP3357996B2 (ja) * 1993-03-26 2002-12-16 ライオン株式会社 金属イオン封鎖性オリゴマー化合物の製造方法及びそのオリゴマー化合物を含む洗浄剤組成物
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
DE4411681A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verfahren zur Herstellung niedermolekularer Polysaccharidether

Also Published As

Publication number Publication date
JP5208707B2 (ja) 2013-06-12
GB2314840A (en) 1998-01-14
JP2000514110A (ja) 2000-10-24
PL189194B1 (pl) 2005-07-29
CZ294839B6 (cs) 2005-03-16
CZ427498A3 (cs) 1999-05-12
BR9710003A (pt) 2000-01-11
AU725296B2 (en) 2000-10-12
DE69702911T2 (de) 2001-02-22
GB9613683D0 (en) 1996-08-28
ATE195742T1 (de) 2000-09-15
GR3034853T3 (en) 2001-02-28
JP2009102645A (ja) 2009-05-14
ES2148991T3 (es) 2000-10-16
GB2314840B (en) 2000-09-06
JP4302187B2 (ja) 2009-07-22
CA2258849A1 (en) 1998-01-08
PT907664E (pt) 2000-12-29
EP0907664B1 (en) 2000-08-23
CA2258849C (en) 2008-01-22
PL330825A1 (en) 1999-06-07
HUP9903404A3 (en) 2001-03-28
EP0907664A1 (en) 1999-04-14
DE69702911D1 (de) 2000-09-28
WO1998000446A1 (en) 1998-01-08
KR20000022286A (ko) 2000-04-25
AU3269397A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
HUP9903404A2 (hu) Oxidált oligoszacharidok
DK0955950T3 (da) Fladtrådsstent
TR200102342T2 (tr) Paramilon içeren dondurularak kurutulmuş madde, bunun üretimi ve kullanımı.
ATE259830T1 (de) Polymerkomplexe von glukuronoglukanen
DK0885261T3 (da) Polylactidfilm
NO990544L (no) Substituerte pyrido- eller pyrimido-inneholdende 6,6 eller 6,7-bycykliske derivater
DE69729864D1 (de) Herstellung von laktamen aus aliphatischen alpha, omega-dinitrilen
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
PT1025125E (pt) Derivativos agregados da insulina humana
BR9711117A (pt) Oligossacarídios modificados.
ID27649A (id) Proses pembuatan kertas
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
HUP9901673A2 (hu) A politrauma utáni többszörös szervelégtelenség megakadályozására, valamint az extracorporeális vérkeringés utáni akut szerv károsodás megakadályozására szolgáló anti-szelektin antitestek
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
SE9602822D0 (sv) New receptor
YU31697A (sh) Varijante aprotinina sa poboljšanim svojstvima
DE69623700D1 (de) Turbomolekularpumpe
PE20399A1 (es) Muteina ob
WO1999051189A3 (de) Haftmittel für zahnprothesen
DE69702961D1 (de) Herstellung von 1,1-difluorethan
DE59712246D1 (de) Kollagenfreie kosmetische zubereitungen aus vernetzten chitosan hydrogelen hergestellt
HUP0100774A2 (hu) Keményítőt vagy keményítőszármazékokat tartalmazó műbél
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
ES2122641T3 (es) Composiciones de revestimiento resistentes.
TR199900555T2 (xx) Vir�slerin v�cuda yeniden yerle�mesini �nleyici madde olarak proteinerin kullan�m�.